SIO2023 Program

*Ablation Master Class: Liver & Kidney Ablation

Moderators: Ron Arellano, MD, Massachusetts General Hospital; Martijn Meijerink, MD, PhD, Amsterdam UMC

• Liver: Diaphragm, Gallbladder & Bowel, Ron Arellano, MD, Massachusetts General Hospital
• Liver: Perivascular Lesions, Martijn Meijerink, MD, PhD, Amsterdam UMC
• Kidney: Difficult to Reach Lesions, Andrew Taylor, MD, PhD, University of California San Francisco 
• Kidney: Collecting System Protection, AJ Gunn, MD, University of Alabama at Birmingham

*Ablation Master Class: Lung, Adrenal & Pancreas Ablation

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Marwan Moussa, MD, Beth Israel Deaconess Medical Center

• Lung: Pearls & Pitfalls, Frederic Deschamps, MD, PhD, Gustave Roussy
• Lung: Chest Wall Lesions, Damian Dupuy, MD, FACR, Cape Cod Hospital
• Adrenal Ablation: Staying Out of Trouble, Marwan Moussa, MD, Beth Israel Deaconess Medical Center
• Pancreas Ablation, Martijn Meijerink, MD, PhD, Amsterdam UMC

*Ablation Master Class: MSK Pain Palliation

Moderators: Jack Jennings, MD, PhD, Washington University St. Louis; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens; Franco Orsi, MD, European Institute of Oncology

• Ablation Neurolysis, Neil J. Resnick, MD, Emory University
• Appendicular Skeletal Lesions, Jack Jennings, MD, PhD, Washington University St. Louis
• Pelvic Stabilization & Ablation, Steven Yevich, MD, MPH, MD Anderson Cancer Center
• Vertebral Augmentation Combined with Ablation, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens

*Ablation Master Class: Emerging Techniques

Moderators: Afshin Gangi, MD, University Hospital of Strasbourg; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

• Thyroid Ablation, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
• Breast Ablation, Alan Alper Sag, MD, Duke University Medical Center
• Prostate Ablation, Afshin Gangi, MD, University Hospital of Strasbourg
• Lymph Node Ablation, Dimitrios Filippiadis MD, PhD, MSc, EBIR, University of Athens

Breakfast & Industry Symposium Presented by Stryker - Bone Tumor Ablation with Stryker's OptaBlate System

• Reade De Leacy, MD, Mount Sinai

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

• President's Welcome, Matthew Callstrom, MD, PhD, Mayo Clinic
• Meeting Intro & Thanks, Damian Dupuy, MD, FACR, Cape Cod Hospital
• Laudation, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
• Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center

Patient-Centered IO Care

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

• Whole Patient Approach to IO, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Extending Life & Living with Chronic Cancer, Angela Laffan, NP, MSN, University of California San Francisco
• Death & Dying: Realistic Expectations, Cristal Brown, MD, MHS, University of Texas at Austin Dell Medical School
• Caring for Those Who Care: Families & Physicians, Janice Newsome, MD, Emory University
• Survivorship: Patient Perspective, Lynn Lazzaro, Valley Advisors

Expo Hall Break - Discovery Theater Presentation by Guerbet

HCC Managment in 2023: Moving Towards a More Targeted Treatment Delivery, Pav Najran, MD

Immuno-oncology

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

• Basics of Immunology, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• Immunoadjuvants for Ablation, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Tumor DNA Research, Mark Yarchoan, MD, Johns Hopkins Univesity
• Immunotherapy Pipeline, Gordon Cohen, MD, AstraZeneca

Advanced Glass Y90 Radioembolization

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Riad Salem, MD, MBA, Northwestern University

• Understanding the Basic Science of Glass Microspheres, Nora Tabori, MD, MedStar
• Absorbed Dose Dosimetric Principles, Beau Toskich, MD, Mayo Clinic
• HCC with PVT: The Past, Present & Future, Robert Lewandowski, MD, FSIR, Northwestern Medicine
• Applying the Outcomes of EPOCH, Riad Salem, MD, MBA, Northwestern University
• Case Discussions, All

SIO Meets International IO Societies

Moderators: Frederic Deschamps, MD, PhD, Gustave Roussy; David Breen, MD, MRCP, FRCR, University Hospitals Southampton

• CIRSE, Laura Crocetti, MD, PhD, University of Pisa
• JSIR, Koichiro Yamakado, MD, PHD, Hyogo College of Medicine
• SOBRICE, Marcos Menezes, PhD, Hospital da Clinicas da Universidade de Sao Paulo
• PAIRS, Mohammad Arabi, MD, King Abdulaziz Medical Center

Expo Hall Afternoon Hours - Discovery Theater Presentation by Genentech

Advancement in the 1L Treatment of Unresectable or Metastatic HCC, Ripal Gandhi, MD

Expo Hall Networking & Oral Poster Presentations 

• Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Evaluation of Morphological factors affecting the outcome, Ornella Moschovaki-Zeiger, MD, "Attikon" University General Hospital of Athens/Greece
• Safety and efficacy of histotripsy delivery through overlying gas-filled bowel in an ex vivo swine model, Meredith Kisting, MA, University of Wisconsin
• The Diagnostic Value of Transcatheter CTHA for Intraprocedural Detection of previously unknown CRLM during Percutaneous Ablation and Impact on Treatment plan, Susan van der Lei, MD, PhD, Amsterdam UMC

Hands-On: Ablation

Renal/Adrenal 

Moderators: Philippe Periera, MD, SLK Kliniken; Ron Arellano, MD, Massachusetts General Hospital

• State of the Art Treatment of Stage 1 RCC: Ablative Techniques, Debra Gervais, MD, Massachusetts General Hospital
• Know Your Real Estate: Techniques to Reduce Collateral Injuries, AJ Gunn, MD, University of Alabama at Birmingham
• Changing Landscape of Early RCC Treatment, David Breen, MD, MRCP, FRCR, University Hospitals Southampton
• Adrenal: Primary & Metastatic Disease, Marwan Moussa, MD, Beth Israel Deaconess Medical Center

HCC: 2023 Updates

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

• Y90 Dosing/Cholangio, Zach Berman, MD, University of California San Diego
• BCLC in Evolution, David Madoff, MD, Yale School of Medicine
• Current Evidence for Systemic Treatment, Marina Baretti, MD, Johns Hopkins University
• Pros & Cons of Ablative Modalities in the Liver, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
• Reinventing TACE: The Role of Embolics, Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

HCC/Cholangio Tumor Board

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

Panelists: Zach Berman, MD, University of California San Diego; David Madoff, MD, Yale School of Medicine; Marina Baretti, MD, Johns Hopkins University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Jennifer Berumen. MD, University of California San Diego; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

Breakfast & Education Session - Optimal Preparation and Treatment Endpoints in cTACE

• Sarah White, MD, MS, Medical College of Wisconsin
• William Rilling, MD, FSIR, Medical College of Wisconsin
• Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
• Nicholas Fidelman, MD, University of California San Francisco

Y90 Radioembolization for Primary & Metastatic Liver Cancer: One Size Does Not Fit All

Moderators: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute

• Lung Shunt & Lung Dose Considerations,  Marnix Lam, MD, PhD, University Medical Center Utrecht
• Multi-Compartment Dosimetry, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute
• Dosimetry in Ablative Setting: Resin versus Glass, Beau Toskich, MD, Mayo Clinic
• Dosimetry in Non-Ablative Setting: Resin versus Glass, Nima Kokabi, MD, Emory University
• Post-Treatment Imaging: SPECT versus PET, S. Cheenu Kappadath, PhD, MD Anderson Cancer Center

Scientific Oral Abstracts

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

• Bone Ablation with a Saline-Infused System, Amanda Smolock, MD, PhD, Medical College of Wisconsin
• Radiomics-based predictive models for new intrahepatic tumors following thermal ablation of colorectal liver metastasis, Iwan Paolucci, PhD, The University of Texas MD Anderson Cancer Center
• Is the minimal ablative margin measured on intraprocedural post-ablation CT better than first follow-up CT in predicting colorectal liver metastasis outcomes? Yuan-Mao Lin, MD, The University of Texas MD Anderson Cancer Center
• Circulating miR-21 as a prognostic biomarker for HCC treated with CT-guided high-dose rate brachytherapy, Matthias Stechele, MD, University Hospital, LMU Munich
• An injectable intratumoral immunoadjuvant depot overcomes check-point inhibitor resistant cancer at distant tumor sites through local immune system stimulation, Avik Som, MD, PhD, MGH
• MRI-guided trans-perineal focal cryoablation for primary prostate cancer, Aliza Mushtaq, MD, Mayo Clinic
• Immediate 3D Imaging Assessment is the Most Accurate Predictor of Local Tumor Progression after Microwave Ablation of CRC Liver Metastases, Mahdi Zirakchian Zadeh, MD, Memorial Sloan Kettering Cancer Center
• Development of Patient-Derived Hepatocellular Carcinoma (HCC) Tumoroids as a Platform for Preclinical Investigations of Liver-Directed Therapies, Christopher Malone, MD, Mallinckrodt Institute of Radiology at Washington University School of Medicine

Expo Hall Break - Discovery Theater Presentation by Varian, a Siemens Healthineers Company

Image-Guided Cryoablation and Embolization in MSK: MSK Intervention with Cryotherapy and Embolization Using Integrated Angio-CT Solutions, Rahul Anil Sheth, MD

Managing Post-Treatment & Surgical Complications: M&M

Moderators: Anne Covey, MD, Memorial Sloan Kettering Cancer Center; Kirema Garcia-Reyes, MD, Mount Sinai Hospital

• Hepatobiliary Interventions: Surgeon Perspective, Betsy King, MD, PhD, Johns Hopkins University
• Hepatobiliary Interventions: IR Perspective, Lynn Brody, MD, Memorial Sloan Kettering Cancer Center
• GU Interventions Post-Ablation: IR Perspective, Andrew Taylor, , MD, PhD, University of California San Francisco 
• Lymphatic Interventions: Not Out of Sight Out of Mind, Maxim Itkin, MD, University of Pennsylvania

Palliative Care Case Examples

Moderators: Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens; Nicholas Fidelman, MD, University of California San Francisco

• Vertebral Augmentation, Ablation & Bone Pain, Steven Yevich, MD, MPH, MD Anderson Cancer Center
• Nerve Ablation, Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens
• PTEG, Gina Landinez, MD, University of California San Francisco
• Electro-Chemotherapy for Tumors with Epidural Extension, Frederic Deschamps, MD, PhD, Gustave Roussy

Liver Directed Therapy for Early Stage HCC

Moderators: Kelvin Hong, MD, Johns Hopkins University; Laura Crocetti, MD, PhD, University of Pisa

• Surgical Approach, Andrew Cameron, MD, PhD, Johns Hopkins University
• Arterial Approach, Kelvin Hong, MD, Johns Hopkins University
• Ablation, Laura Crocetti, MD, PhD, University of Pisa
• Radiation Oncology, Amol Narang, MD, Johns Hopkins University

Expo Hall Afternoon Hours - Discovery Theater Presentation by Varian, a Siemens Healthineers Company

Is Access to Interventional Oncology Care in the US Equitable? Geographic Access to Interventional Oncology Care in the USA, Theresa M. Caridi, MD, FSIR

Women & Under-Represented Minorities in IO

Moderators: Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

• Setting the Stage, Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Changing the Pipeline, Culture & Environment, Amy Deipolyi, MD, PhD, West Virginia University & Sherri Reed, Research Fellow, NIH
• Pigeonholing & Imposter Syndrome, Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill & Kirema Garcia-Reyes, MD, Mount Sinai Hospital
• He for She & Male Portraiture, Brad Wood, MD, NIH & Nicole Varble, NIH
• Panel Discussion

Planning Committee: Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill; Ji Buethe, MD, Johns Hopkins University; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Sharon Kwan, MD, MS, Seattle Cancer Care Alliance

Expo Hall Networking & Oral Poster Presentations

• Fusion-Guided Optical Molecular Imaging Liver Biopsy and Point-of-Care Tissue Assessment for Liver Neoplasms, Michael Kassin, MD, NIH
• Microwave Ablation of Stage IA Non-Small Cell Lung Cancers Detected at Low Dose CT Lung Cancer Screening in US Veterans: Midterm Results, Ericson John Torralba, Wright State University Boonshoft School of Medicine
• Rapid Diagnosis through IR Outpatient Clinic to Expedite Triage for Patients without a Cancer Diagnosis and Diffuse Imaging Findings Suggestive of Cancer, Suken Shah, MD, Memorial Sloan Kettering Cancer Center

Hands-On: Navigation & Guidance

Sarcoma

Moderators: Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center; Jack Jennings, MD, PhD, Washington University St. Louis

• Sarcoma & Immunotherapy, Peter Rydesky, MD, Rochester Radiology Associates
• What Ablation Can Add to Systemic & Immuno Therapy, Christian Meyer, MD, PhD, MS, Johns Hopkins University
• Intratumor Injections & Immunotherapy, Rahul Sheth, MD, MD Anderson Cancer Center
• Update on Ablation for Sarcoma Data Outcomes, Florian Fintelmann, MD, Massachusetts General Hospital

Breast

Moderators: Kenneth Tomkovich, MD, Princeton; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center

• Current Status, Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center
• Patient Selection & Indications for Ablation in Breast, Kenneth Tomkovich, MD, Princeton
• Cryo, Robert Ward, MD, Brown University
• New Horizons in Breast Intervention, Peter Littrup, MD, Ascension Providence Rochester Hospital
• Treatment of Metastatic Disease, Amy Diepolyi, MD, PhD, West Virginia University

GU/Bone Tumor Board

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens

Panelists: David Einstein, MD, Beth Israel Deaconess Medical Center; Steven Yevich, MD, MPH, MD Anderson Cancer Center; Damian Dupuy, MD, FACR, Cape Cod Hospital

HCC New Horizons

• Introduction & Laudation, Julius Chapiro, MD, PhD, Yale University School of Medicine
• HCC New Horizons Keynote, David Madoff, MD, Yale School of Medicine

Scientific Oral Abstracts

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

• Effect of injection rate on bead distribution and volume delivered during embolization in swine: Results from the AmCORE, Antonio Arrichiello, MD, National Institutes of Health
• Optimizing patient selection for treating colorectal liver metastases with glass radioembolization plus chemotherapy: The EPOCH study, Riad Salem, MD, MBA, Northwestern University
• Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization for Chemo-refractory Colorectal Liver Metastases, Nicholas Fidelman, MD, University of California San Francisco
• Enhanced Delivery of a TLR9 Type C Agonist SD-101 to Liver Tumors in the Oncopig using Pressure Enabled Drug Delivery (PEDD) Versus a Standard Endhole Catheter, Thomas Hullinger, PhD, TriSalus Life Sciences
• Radiofrequency ablation induced tumor growth is suppressed by microRNA21 inhibition, Lukas Salvermoser, MD, University Hospital Munich
• MRI Radiomics Correlate with Clinical Outcomes of Peripheral Venous Malformations Following Percutaneous Sclerotherapy, Adham Khalil, MD, Johns Hopkins University
• Does Cancer Type Influence the Rate of Port Associated Infection? Alirezsa Zandifar, MD, Children's Hospital of Philadelphia

Expo Hall Break - Discovery Theater Presentation by XACT Robotics

Advancements in Robotic Percutaneous Procedures, Francois H. Cornelis, MD, PhD

MSK

Moderators: Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego; Alan Alper Sag, MD, Duke University Medical Center

• Desmoids, Marwan Moussa, MD, Beth Israel Deaconess Medical Center
• Cement & Screws: Evidence, Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego
• Pre-Surgical Embolization, Rahul Sheth, MD, MD Anderson Cancer Center
• Pain Palliation, Neil J. Resnick, MD, Emory University
• MSK Pain Palliation: Anesthesiologist Perspective, Allan Gottschalk, MD, PhD, Johns Hopkins University

Combination Therapies

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Nicholas Fidelman, MD, University of California San Francisco

• Combination with Immunotherapy, Lambros Tselikas, MD, Gustave Roussy
• Lung: Endobronchial Techniques, Matt Kinsey, MD, University of Vermont Medical Center
• LDT in Combination with Targeted Agents for HCC, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
• Y90 in Combination with Radiosensitizing Chemotherapy, Nicholas Fidelman, MD, University of California San Francisco
• Combination Radiotherapy & Ablative Techniques for Lung Cancer, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania

Combined Locoregional & Immunotherapy of HCC Grant Update

Moderator: Julius Chapiro, MD, PhD, Yale University School of Medicine

• SIO Grant Program Report, Julius Chapiro, MD, PhD, Yale University School of Medicine
• Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center
• Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, MD Anderson Cancer Center
• Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
• Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, Kelley Weinfurtner, MD, University of Pennsylvania

Lunch & Industry Symposium Presented by AstraZeneca - Newly Approved Treatment Options for Unresectable Hepatocellular Carcinoma 

• Bassam Estfan, MD, Cleveland Clinic

Lunch & Education Session - HCC Imaging and Chemoembolization 2023: New Techniques, New Science

Moderator: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

• Latest Guidelines and Randomized Trials, Lambros Tselikas, MD, Gustave Roussy
• Biomarkers in Liver Cancer Therapy, Julius Chapiro, MD, PhD, Yale University School of Medicine

Expo Hall Afternoon Hours - Discovery Theater Presentation by Instylla

Embrace (TM) HES for Tumor Embolization, Stephen Hunt, MD

AI

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

• Publishing AI Research: What an Author Needs to Know, Iwan Paolucci, PhD, MD Anderson Cancer Center
• AI in Interventional Oncology: Top 10 Papers, Lynne Martin, MD, Stanford University
• Public Databases and Data Policies: An Overview, Lynn Savic, MD, Universitatsmedizin Charite Berlin
• Learning the Language of AI: How I Do It as an MD, Aaron Abajian, MD, MS, Memorial Sloan Kettering Cancer Center
• Building Academic-Industrial Partnerships in AI, Rajesh Shah, MD, Stanford University

Lung Cancer & Mets

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Alda Tam, MD, MD Anderson Cancer Center

• Cutting Edge Clinical Trials in Lung Ablation, Alda Tam, MD, MD Anderson Cancer Center
• Combination Immunotherapy, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
• Oligonodular Disease: Changing Landscape, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
• Thermal Therapy Considerations, Beau Toskich, MD, Mayo Clinic
• Hot Topics in Trial Design for Minimally Invasive Procedures, Florian Fintelmann, MD, Massachusetts General Hospital

Head, Neck & Neuro

Moderators: Frederic Deschamps, MD, PhD, Gustave Roussy; Rony Avritscher, MD, MD Anderson Cancer Center

• Laser Ablation for Head & Neck Tumors, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
• Y90 for GBM, Riad Salem, MD, MBA, Northwestern University
• Lipiodol for Head & Neck Tumors, Kazim Narsinh, MD, University of California San Francisco

Expo Hall Networking & Oral Poster Presentations

• Clinical Feasibility of CT-based Dosimetry in Yttrium-90 Radioembolization Following the Administration of Radiopaque Glass Microspheres (Eye90), Robert Abraham, MD, Dalhousie University
• Targeting for Transcostal Histotripsy: Effect of Intervening Ribs on the Location of Cavitation, Katrina Falk, MS, University of Wisconsin-Madison
• Temporary Transvenous Pacer to Avoid Hypertensive Crisis during Percutaneous Ablation of Adrenal Metastasis: a single-center experience, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center

Hands-On: Treatment Planning & Simulations

Liver Mets

Moderator: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

• Y90 for Liver Mets, Edward Kim, MD, Mount Sinai Health Systems
• Latest Radioembolization Trials for Colorectal Cancer, Mary Mulcahy, MD, Northwestern University
• Updates on Neuroendocrine, Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
• Combination Approaches to Metastatic Disease, Nicholas Fidelman, MD, University of California San Francisco

Prostate

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; David Woodrum, MD, PhD, Mayo Clinic

• Current Status of Prostate Cancer, Lance Mynderse, MD, Mayo Clinic
• Prostate Anatomy, David Woodrum, MD, PhD, Mayo Clinic
• CT-Guided Treatment for Prostate Cancer, Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center
• MRI-Guided Laser Therapy for Prostate Cancer Treatment, Eric Walser, MD, University of Texas Medical Branch
• Prostate Imaging, Daniel Adamo, MD, Mayo Clinic

Liver Mets Tumor Board

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

Panelists: Kelly Lafaro, Md, Johns Hopkins University; Mary Mulcahy, MD, Northwestern University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Nicholas Fidelman, MD, University of California San Francisco; Bruno Odisio, MD, FSIR, MD Anderson Cancer Center

Technology

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Joseph Amaral, MD, Histosonics Institute

• Pulsed Electric Fields, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
• Histotripsy, Timothy Ziemlewicz, MD, UW Madison
• Robotic Endoscopy for Lung Cancer, Michael Pritchett, DO, MPH, Pinehurst Medical
• Bronchoscopic Lung Microwave Ablation, Michael Pritchett, DO, MPH, Pinehurst Medical
• Treatment Planning, Punit Prakash, PhD, Kansas State University

Case-Based Review

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; R. Peter Lokken, MD, MPH, FSIR University of California San Francisco

• Liver Embolization, Christos Georgiades, MD, PhD, Johns Hopkins University
• Liver Ablation, Bruno Odisio, MD, FSIR, MD Anderson Cancer Center
• Renal, Ryan Kohlbrenner, MD, University of California San Francisco
• Lung, Ji Buethe, MD, Johns Hopkins University
• MSK, A. Nick Kurup, MD, Mayo Clinic
• Complications: Miss, R. Peter Lokken, MD, MPH, FSIR University of California San Francisco
• Complications: Save, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center

Closing Remarks

Matthew Callstrom, MD, PhD, Mayo Clinic